“…A subset of patients receiving primary concurrent chemo-radiotherapy (CCRT) for cervical cancer exhibit an accelerated disease progression and a mortality rate that surpasses prognostic expectations [ 1 ]. This phenomenon of early death (ED) has been documented in various cancer types, including breast, stomach, lung, head and neck, colorectal, and bladder cancers, and it is potentially resistant to the three predominant cancer treatment modalities, namely surgery, chemotherapy, and radiation therapy (RT) [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 ].…”